Dalrada Financial Corporation establishes Deposition Technology Inc. U.S. Presence with New Portland Facility
“The opening of our Portland facility is a major milestone in advancing Dalrada’s mission to deliver sustainable innovation and next-gen technologies globally.” – Brian Bonar, Dalrada Chairman and CEO.
Dalrada’s latest expansion strengthens the company’s ability to deliver innovative solutions in the semiconductor and microchip sectors while bolstering its climate and sustainability technologies across the U.S. market.
Deposition Technology USA’s new Portland facility will enhance collaboration between Dalrada’s U.S. and Scotland teams, enabling faster delivery, localized research and development, and improved customer support. It also reinforces Dalrada’s dedication to reducing carbon footprints while advancing sustainable practices. Read More!
Visit our New Website
Explore the all-new Deposition Technology USA (Deptec) website! Since 2004, Deptec has been a global leader in PVD and CVD solutions, supporting industries like semiconductors, MEMS, and medical devices. Browse all of our precision manufacturing services and projects. Visit Now!
Read Our Latest Blog
The semiconductor industry continues to prioritize 150mm and 200mm wafers for key applications in automotive, industrial, and consumer electronics. These sizes remain vital for legacy nodes, energy-efficient devices, and emerging tech, despite trends toward larger wafers. Read More!
About Dalrada Corporation
Dalrada Financial Corporation (OTC: DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy Physical Vapor Deposition and Semiconductor, and Health Care sectors. Dalrada’s core segments include Dalrada Climate Technology, which offers cutting-edge heat pump technology for industrial and residential applications;?Deptec, an international leader in deposition technology and manufacturing that repurposes and sells proprietary semiconductor technology for clean energy applications; and Genefic Specialty Pharmacy, which provides end-to-end prescription services as well as patient advocacy and support.
Dalrada consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.
For more information, please follow us on LinkedIn, Facebook, Twitter, and YouTube Channel.